Health
New CRISPR system edits body’s response to prevent immunity against AAVs – Drug Target Review
A CRISPR system that suppresses AAV antibody production has been developed to prevent immunity against the gene therapy.

Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
A novel CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production has been developed to prevent immunity against the gene therapy.
Researchers have created a new CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production so that the virus can deliver its cargo unimpeded.
According to the researchers from the University of Pittsburgh School…
-
General9 hours ago
RSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General12 hours ago
Self-taught child drummer makes rock band debut with The Living End
-
Noosa News16 hours ago
Wave of cruises headed for Sunshine Coast this summer
-
General20 hours ago
NewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’